期刊文献+

KKXX-motif对VKORC1亚细胞定位的影响

Influence of KKXX-motif on VKORC1 Subcellular Localization
下载PDF
导出
摘要 目的研究细胞内质网蛋白贮留信号KKXX-motif,对维生素K环氧化物还原酶复合物亚基1(VKORC1)的亚细胞定位的作用。方法利用点突变试剂盒构建VKORC1的KKXX突变体——VKORC1-SSXX;同时应用pEGFP载体构建VKORC1-SSXX和VKORC1-KKXX的绿色荧光融合蛋白表达质粒。瞬时转染HEK293s细胞,观察野生融合蛋白和突变融合蛋白的表达情况。结果野生型融合蛋白荧光分布在胞浆内,而突变型融合蛋白聚集表达。结论KKXX-motif影响了VKORC1的亚细胞定位。 Objective To determine whether the KKXX-motif can influence the subcellular localization of VKORC1. Methods The mutant VKORC1-SSXX was made by site-directed mutagenesis. The motif KAKRH was substituted by SASRH. The wild and mutant VKORC1 were cloned into pEGFP-C2 vector respectively. Then the constructed plasmids were transiently transfected to HEK293s cells, which were observed under confocal microscope. Results Subcellular fraction revealed that GFP staining diffused in cytoplasmic compartment and nucleus in the cells transfected with control vector, predominantly in the cytoplasm of the cells transfected with GFP-VKORC1. By contrast, the mutant VKORC1-SSXX was expressed in an accumulated pattern in cells. Conclusion KKXX-motif could influence VKORC1 subcellular localization.
出处 《中国比较医学杂志》 CAS 2008年第5期13-15,I0003,共4页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金(项目批准号30740014)
关键词 VKORC1 KKXX-motif 亚细胞定位 VKORC1 KKXX-motif Subcellular localization
  • 相关文献

参考文献9

  • 1Nelsestuen GL, Zytkovicz TH, Howard JB. The mode of action of vitamin K. Identification of γ-carboxyglutamic acid as a component of prothrombin[ J]. J Biol Chem, 1974, 249:6347 - 6350.
  • 2Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORCI cause warfarin resistance and multiple coagulation factor deficiency type 2[J]. Nature, 2004, 427: 537- 541.
  • 3Li T, Chang CY, Jin DY, et al. Identification of the gene for vitamin K epoxide reductase[J]. Nature, 2004, 427:541 -544.
  • 4WangY, Zhen Y, Shi Y, et al. Vitamin K epoxide reduetase: a protein involved in angiogenesis[ J]. Mol Cancer Res, 2005, 3:317 - 323.
  • 5Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORCI haplotypes on transcriptional regulation and warfarin dose[J]. N Engl J Med, 2005, 352:2285 - 2293.
  • 6Wang Y, Zhang W, Zhang Y, et al. VKORCI haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease and aortic dissection)[J]. Cireulation, 2006, 113:1615 - 1621.
  • 7Lacut K, Larramendy-Gozalo C, Le Gal G, et al. Vitamin K epoxide reductuse genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study[J]. J Thromb Haemost, 2007, 5 : 2020 - 2024.
  • 8唐和年,张总刚,杜宇奎.新疆汉族和维吾尔族健康人群VKORC1启动子区基因多态性研究[J].中国优生与遗传杂志,2007,15(3):16-18. 被引量:12
  • 9Lontok E, Corse E, Machamer CE. Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site[J]. J Virol, 2004, 78:5913 - 5922.

二级参考文献19

  • 1Goodstadt L, Ponting CP, Vitanm K. Epoxide reductase: homology, active site and catalytiemechanism[J]. Trends Biochem Sci ,2004,29 : 189 -92.
  • 2Rost S, Fregin A, Ivaskevlclus V, et al. Murations in VKORCI cause warfarin resistance and multiple coagulation factor defic iency type 2 [J]. Nature ,2004,427:537 -41.
  • 3Hsiang - Yu Yuan, Jin - Jer Chen, Ju - Chieh Wung, et al. A novel functional VKORCI promoter polymorphism is associated with interindividual and inter - ethnic differcence in warfarin sensitivity [ J ]. Fluman Molecular Genetics,2005,4 : 1745 - 1751.
  • 4Elizabeth A Sconece, Tayyaba I Khan, Hilary A, et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen[J]. Blood ,2005,106:2329 - 2333.
  • 5Geiser C, Watnka M, Sittingger K, et al. VKORC1 haplotypes and their impact on the inter - individual and inter - ethnical variability of oral anticoagulation [J]. Thromb Haemost,2005 ,94 :773 - 9.
  • 6Bodin L,Verstuyft C,Tregouet DA,et al. Cytochrome P4502C9(CYP2C9) and Vitamin Z epoxide reductase(VKORC1)genotypes as determinants of acenocoumarol sensitivity[J]. Blood ,2005 ,106 :135 -40.
  • 7Li T,et al. Identification of the gene for vitamin K epoxide reductase [ J ]. Nature ,2004,427:541 - 544.
  • 8Blood Coagulation :VKOBC 1 is a key regulatory protein in synthesis of active vitamin K - dependent proteins [J]. World Disease Weekly, 2005. 203.
  • 9Harrington D J, et al. Pharmacodynamic resistance to warfarin associated with a Va166Met substitution in vitamin K epoxide reductase complex subunit 1 [J]. Thromb Haemost,2005 ,93 :23 -26.
  • 10Oldenburg J,Bevans CG,Muller CR,et al. Vitamin K epoxide reductase complex subunit 1 (VKORC1) :the key protein of the vitamin K cycle [ J ]. Antioxid Redox Signal ,2006,8:347 - 353.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部